3.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Barclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - MSN
What makes Relay Therapeutics Inc. stock price move sharplyUnprecedented profits - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How does Relay Therapeutics Inc. generate profit in a changing economyOutstanding stock performance - Jammu Links News
Should I hold or sell Relay Therapeutics Inc. stock in 2025Build a winning investment strategy today - Jammu Links News
Is Relay Therapeutics Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Unlock exclusive stock market insights - Jammu Links News
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionStay ahead with daily expert stock picks - Jammu Links News
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Discover stocks with superior performance - Jammu Links News
What drives Relay Therapeutics Inc. stock priceMaximize portfolio growth with professional advice - Jammu Links News
How does Relay Therapeutics Inc. compare to its industry peersGet alerts on high-potential market moves - Jammu Links News
Relay Therapeutics (RLAY): Is H2 2025 the Inflection Point for AI-Driven Drug Discovery? - AInvest
Relay Therapeutics: What's Next For H2 2025? - Seeking Alpha
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - 富途牛牛
Relay Therapeutics Q2 2025 Financial Results and Corporate Highlights Announced for August 7, 2025 - AInvest
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment - TipRanks
Barclays Reiterates a Buy Rating on Relay Therapeutics (RLAY) - MSN
Relay Therapeutics president sells $113k in stock By Investing.com - Investing.com Canada
Rahmer Peter sells Relay Therapeutics (RLAY) stock worth $62,946 By Investing.com - Investing.com Canada
Relay Therapeutics CFO Catinazzo sells $74,000 in stock By Investing.com - Investing.com Canada
Relay Therapeutics CFO Catinazzo sells $74,000 in stock - Investing.com
Relay Therapeutics president sells $113k in stock - Investing.com
Relay Therapeutics Executives Sell Shares - TradingView
Published on: 2025-07-29 23:02:46 - metal.it
Relay Therapeutics has positive read from Celcuity data, says Barclays - The Globe and Mail
Published on: 2025-07-29 04:36:35 - beatles.ru
What is the risk reward ratio of investing in Relay Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - Jammu Links News
When is Relay Therapeutics Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - Jammu Links News
Price Floor Holding on Relay Therapeutics Inc. — Rebound PossibleProfit Focused Stock Screener Results Released - metal.it
What are the technical indicators suggesting about Relay Therapeutics Inc.Achieve breakthrough performance in the market - jammulinksnews.com
What are Relay Therapeutics Inc. company’s key revenue driversGet expert analysis on top stock picks - jammulinksnews.com
Does Relay Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough investment performance - Jammu Links News
Is Relay Therapeutics Inc. a growth stock or a value stockGet daily updates on the hottest stocks - Jammu Links News
Is Relay Therapeutics Inc. stock overvalued or undervaluedExplosive capital appreciation - jammulinksnews.com
Published on: 2025-07-27 23:12:22 - Jammu Links News
Why Relay Therapeutics Inc. stock attracts strong analyst attentionFree Stock Investment Growth Plan - metal.it
What analysts say about Relay Therapeutics Inc. stockExceptional growth trajectory - PrintWeekIndia
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):